We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
It is particularly difficult to treat some groups of childhood cancer patients, especially infants in their first weeks of life. This application is to fund this rapidly developing research programme for two years, involving the treatment of 150-200.
Looking at whether medicines that prevent circular DNA replication can help prevent relapse.
Studying how neuroblastoma cells and immune cells interact over time to see how the cancer adapts to treatment.
Creating an immunotherapy that can be delivered to patients more quickly and cost-effectively.
Testing a new type of targeted treatment that applies to multiple types of childhood cancers.
Looking at how cancer cells alter the scaffolding inside the body that organises cells in order to spread and make new tumours.
Looking at how brain tumours hijack immune cells, forcing them to support cancer growth instead of fighting it.
Testing medicines that can correct the genetic messages that help cancer cells grow out of control.
Developing a new dye to make kidney cancer surgery safer and more effective.
